{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:28:11Z","timestamp":1760120891455},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":4033,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1046\/j.1524-4733.2002.54145.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T23:34:06Z","timestamp":1047512046000},"page":"312-328","source":"Crossref","is-referenced-by-count":23,"title":["Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn"],"prefix":"10.1016","volume":"5","author":[{"given":"Ron","family":"Goeree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernie J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Blackhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rameeta","family":"Lad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1524-4733.2002.54145.x_bib10","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1572-0241.1999.01427.x","article-title":"Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study","volume":"94","author":"Tougas","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(97)00308-2","article-title":"Costs of acid-related disorders to a health maintenance organization","volume":"103","author":"Levin","year":"1997","journal-title":"Am J Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2000.01861.x","article-title":"Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization","volume":"95","author":"Henke","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004836-199912000-00009","article-title":"A national survey of practice patterns of gastroenterologists with comparison to the past two decades","volume":"29","author":"Russo","year":"1999","journal-title":"J Clin Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib50","first-page":"451","article-title":"Long-term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin","year":"1999","journal-title":"Brit J Gen Pract"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib60","first-page":"257","article-title":"Why do apparently healthy people use antacid tablets?","volume":"78","author":"Graham","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib70","first-page":"A1486","article-title":"Symptom relief in erosive GERD: a meta-analysis","volume":"88","author":"Chiba","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib80","first-page":"A53","article-title":"Rapidity of healing in GERD: a comparison of different drug classes by meta-analysis","volume":"104","author":"Chiba","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00019053-199916060-00007","article-title":"Economic evaluation of long-term management strategies for erosive oesophagitis","volume":"16","author":"Goeree","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib100","first-page":"2179","article-title":"Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis","volume":"92","author":"Harris","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms in gastro-esophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"Lancet"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/13814789509161628","article-title":"Gastro-esophageal reflux disease disease in primary care in Europe: clinical presentation and endoscopic findings","volume":"1","author":"Jones","year":"1995","journal-title":"Eur J Gen Pract"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib130","first-page":"S3","article-title":"An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori: the Canadian Dyspepsia Working Group","volume":"162","author":"Veldhuyzen van Zanten","year":"2000","journal-title":"CMAJ"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib140","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in Grade II to IV gastroesophegial reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1525-1497.2000.02639.x","article-title":"What is heartburn worth: a cost-utility analysis of management strategies","volume":"15","author":"Heudebert","year":"2000","journal-title":"J Gent Int Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1572-0241.2000.01759.x","article-title":"A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease","volume":"95","author":"Gerson","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib170","series-title":"Schedule of Benefits: Physician services under the Health Insurance Act","author":"Ontario Ministry of Health","year":"1992"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib180","series-title":"Ontario Case Costing Project: Ontario guide to case costing","author":"Ontario Hospital Association","year":"1995"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib190","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib200","series-title":"Introduction to Statistical Decision Theory. 2nd printing, 1996 ed","author":"Pratt","year":"1995"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib210","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/0272989X9801800209","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib220","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/106002809703100615","article-title":"Controversies surrounding estrogen use in postmenopausal women","volume":"31","author":"Witt","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib250","first-page":"913","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"148","author":"Laupacis","year":"1993","journal-title":"Can Med Assoc J"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib260","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2036.1997.00198.x","article-title":"Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis","volume":"11","author":"Bate","year":"1997","journal-title":"Aliment Phamacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.31.5.509","article-title":"Double-blind comparison of omeprazole (40\u2009mg od) versus cimetidine (400\u2009mg qd) in the treatment of symptomatic erosive reflux oesophagitis assessed endoscopically, histologically and by 24\u2009h pH monitoring","volume":"31","author":"Dehn","year":"1990","journal-title":"Gut"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib280","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.31.9.968","article-title":"Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations","volume":"31","author":"Bate","year":"1990","journal-title":"Gut"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib290","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004836-198708000-00007","article-title":"Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study","volume":"9","author":"Hameeteman","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib300","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0016-5085(78)90133-6","article-title":"Oral cimetidine in reflux esophagitis: A double blind controlled trial","volume":"74","author":"Wesdorp","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004836-198006000-00008","article-title":"Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux","volume":"2","author":"Bright-Asare","year":"1980","journal-title":"J Clin Gastroenterol"},{"issue":"3B","key":"10.1046\/j.1524-4733.2002.54145.x_bib320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(87)90825-4","article-title":"Clinical efficacy of sucralfate in reflux esophagitis. Comparison with cimetidine","volume":"83","author":"Tytgat","year":"1987","journal-title":"Am J Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib330","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/archinte.1991.00400120040007","article-title":"Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group [see comments]","volume":"151","author":"Sabesin","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib340","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.1991.tb00531.x","article-title":"Famotidine (20\u2009mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine\/GERD Investigation Group","volume":"5","author":"Robinson","year":"1991","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib350","first-page":"73","article-title":"A comparison of the efficacy of omeprazole 20\u2009mg once daily with ranitidine 150\u2009mg bid in the relief of symptomatic gastro-oesophageal reflux disease in general practice","volume":"4","author":"Hungin","year":"1993","journal-title":"Brit J Clin Res"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib360","first-page":"133","article-title":"Reflux oesophagitis resolves more rapidly with omeprazole 20\u2009mg once daily than with ranitidine 150\u2009mg bd: omeprazole 40\u2009mg once daily provides further benefit in unresponsive patients","volume":"2","author":"Bate","year":"1991","journal-title":"Brit J Clin Res"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib370","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2036.1992.tb00575.x","article-title":"The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis","volume":"6","author":"Londong","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib380","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(87)91726-0","article-title":"Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis","volume":"1","author":"Klinkenberg-Knol","year":"1987","journal-title":"Lancet"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib390","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF01798351","article-title":"Omeprazole (40\u2009mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis","volume":"33","author":"Vantrappen","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004836-199504000-00005","article-title":"Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study","volume":"20","author":"Koop","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2036.1989.tb00212.x","article-title":"Acute treatment of reflux oesophagitis: a multicentre trial to compare 150\u2009mg ranitidine b.d. with 300\u2009mg ranitidine q.d.s","volume":"3","author":"Johnson","year":"1989","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004836-199210000-00004","article-title":"Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine","volume":"15","author":"Bianchi Porro","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib430","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1365-2036.1999.00527.x","article-title":"Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease\u2014a prospective controlled trial","volume":"13","author":"Maton","year":"1999","journal-title":"Aliment Phamacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib440","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.318.7182.502","article-title":"Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine","volume":"318","author":"Bardhan","year":"1999","journal-title":"BMJ"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib450","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1572-0241.1999.00777.x","article-title":"High-versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: A prospective, controlled trial","volume":"94","author":"Kahrilas","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.1995.tb00363.x","article-title":"Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group","volume":"9","author":"Bardhan","year":"1995","journal-title":"Aliment Phamacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib470","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1742-1241.1994.tb09731.x","article-title":"Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice","volume":"48","author":"Dakkak","year":"1994","journal-title":"Br J Clin Pract"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib480","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.296.6615.89","article-title":"Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial","volume":"296","author":"Havelund","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib490","first-page":"511","article-title":"Omeprazole produces significantly greater healing of erosive or ulcerative reflux oesophagitis than ranitidine. The Italian reflux oesophagitis study group","volume":"3","author":"Italian Reflux Oesophagitis Study","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib500","first-page":"1766","article-title":"Omeprazole versus ranitidine or ranitidine\/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease","volume":"91","author":"Richter","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib510","first-page":"208","article-title":"Investigation of ranitidine 150\u2009mg bd or 300\u2009mg bd in the treatment of reflux disease","volume":"33","author":"Schaub","year":"1986","journal-title":"Hepatogastroenterology"},{"issue":"Suppl. 2","key":"10.1046\/j.1524-4733.2002.54145.x_bib520","first-page":"A45","article-title":"A comparison of omeprazole 10 mg and 20\u2009mg OM with ranitidine 150\u2009mg BD for the treatment of GORD in primary care","volume":"37","author":"Venables","year":"1995","journal-title":"Gut"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib530","first-page":"155","article-title":"Short-term treatment of reflux oesophagitis with ranitidine 300\u2009mg nocte. Italian multicentre study","volume":"34","author":"Bovero","year":"1987","journal-title":"Hepatogastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib540","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(87)90826-6","article-title":"Comparison of the effect of sucralfate and ranitidine in reflux esophagitis","volume":"83","author":"Simon","year":"1987","journal-title":"Am J Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib550","first-page":"769","article-title":"Effect of three ranitidine dosage regimens in the treatment of reflux oesophagitis: results of a multicentre trial","volume":"3","author":"Johnson","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib560","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2036.1997.00185.x","article-title":"Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride","volume":"11","author":"Galmiche","year":"1997","journal-title":"Aliment Phamacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib570","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib580","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0016-5085(92)91790-B","article-title":"Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study","volume":"102","author":"Sontag","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib590","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.1995.tb00388.x","article-title":"A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial","volume":"9","author":"Mossner","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib600","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.1993.tb00125.x","article-title":"Does 40\u2009mg omeprazole daily offer additional benefit over 20\u2009mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? [see comments]","volume":"7","author":"Bate","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.1993.tb00071.x","article-title":"Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis","volume":"7","author":"Robinson","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib620","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.1995.tb00437.x","article-title":"Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study","volume":"9","author":"Corinaldesi","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib630","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.319.7209.550","article-title":"Heartburn treatment in primary care: randomised, double blind study for 8 weeks","volume":"319","author":"Hatlebakk","year":"1999","journal-title":"BMJ"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib640","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2036.1999.00438.x","article-title":"Double-blind, placebo-controlled comparison of rabeprazole 20\u2009mg versus omeprazole 20\u2009mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease","volume":"13","author":"Dekkers","year":"1999","journal-title":"Aliment Phamacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib650","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"10","author":"Bate","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib660","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole","volume":"10","author":"Carlsson","year":"1998","journal-title":"Eur J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib670","first-page":"A110","article-title":"Omeprazole 20\u2009mg or 40\u2009mg daily for the treatment of gastroesophageal reflux disease? A double-blind comparative study","volume":"102","author":"Laursen","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib680","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF02064376","article-title":"Treatment of erosive reflux esophagitis resistant to h2-receptor antagonist therapy. lansoprazole, a new proton pump inhibitor","volume":"40","author":"Robinson","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib690","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00042737-199611000-00013","article-title":"Lansoprazole 30\u2009mg versus omeprazole 40\u2009mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). Dutch Study Group","volume":"8","author":"Mulder","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib700","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.1990.tb00459.x","article-title":"Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to \u201cstandard doses\u201d of H2-receptor antagonists","volume":"4","author":"Lundell","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib710","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/gut.36.4.492","article-title":"Omeprazole 10\u2009mg or 20\u2009mg once daily in the prevention of recurrence of reflux oesophagitis. Solo investigator group","volume":"36","author":"Bate","year":"1995","journal-title":"Gut"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/1997\/954342","article-title":"Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150\u2009mg bid and 300\u2009mg bid","volume":"11","author":"Hegarty","year":"1997","journal-title":"Can J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib730","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/00365529509101589","article-title":"Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study","volume":"30","author":"Laursen","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib740","doi-asserted-by":"crossref","first-page":"859","DOI":"10.7326\/0003-4819-124-10-199605150-00001","article-title":"Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. a randomized, double-blind, placebo-controlled trial","volume":"124","author":"Robinson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib750","first-page":"1758","article-title":"Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group","volume":"91","author":"Sontag","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib760","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0016-5085(94)90531-2","article-title":"Omeprazole or ranitidine in long-term treatment of reflux esophagitis. the scandinavian clinics for united research group [see comments]","volume":"107","author":"Hallerback","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1524-4733.2002.54145.x_bib770","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1996.14156000.x","article-title":"Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis","volume":"10","author":"Gough","year":"1996","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T11:23:27Z","timestamp":1704540207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510600228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1098301510600228"],"URL":"https:\/\/doi.org\/10.1046\/j.1524-4733.2002.54145.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}